Tenet Healthcare earned top marks in the Zacks Style Scores system for growth, receiving an "A" grade that places it in the top 3% of companies for expected earnings and sales acceleration. Analysts note that Tenet's trailing 12-month earnings growth rate of 28% outpaces the 15% average of its hospital services peers. The stock’s three-month sales growth of 9% and projected five-year earnings growth of 18% further reinforce its status as a fast-growing operator in the health-care sector.

Heading into next week’s quarterly report, consensus estimates peg Tenet’s revenue at approximately $4.5 billion, up 12% year-over-year, and earnings per share at $3.10, an increase from $2.80 in the same quarter last year. Wall Street analysts have upgraded their ratings in recent weeks, citing stronger-than-anticipated surgery volumes and margin expansion in the company’s Ambulatory Surgery Center segment. Management has slated the earnings release for Thursday morning, setting the stage for analysts to revise full-year guidance above the current midpoint of $12.50 to $13.00 per share.

While the broader health-care index dipped by 0.8% on Tuesday, Tenet Healthcare bucked the trend with a 2.56% advance, driven by upbeat analyst commentary and expectations of a solid earnings beat. Trading volume climbed 15% above the 30-day average, suggesting institutional buyers stepped in ahead of the quarterly update. Market participants cited increasing patient admissions in Tenet’s Florida and Texas hospital networks as a key catalyst for the stock’s outperformance.

Tenet Healthcare continues to execute on its network optimization plan, having announced five planned hospital divestitures this fiscal year to focus capital on high-growth markets. The company expects proceeds of approximately $600 million from these sales, which will be redeployed into expanding its outpatient surgery business and digital health capabilities. Management reiterated its target of achieving a 25% adjusted operating margin by 2025 through cost reductions, supply-chain efficiencies and continued revenue diversification.